(Q33436696)
Statements
Phase I study of combination therapy with interleukin 2 and beta-interferon in patients with advanced malignancy (English)
Tamura T
Sasaki Y
Shinkai T
Eguchi K
Sakurai M
Fujiwara Y
Nakagawa K
Minato K
Bungo M